Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revascularization in patients with multivessel coronary artery disease: One-year clinical results and total treatment costs

Journal of Invasive Cardiology

Volumn 19, Issue 11, 2007, Pages 469-475

  Varani, Elisabetta ^a   Balducelli, Marco ^a   Vecchi, Giuseppe ^a   Aquilina, Matteo ^a   Maresta, Aleardo ^a  

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

Author keywords

Coronary disease; Costs; Revascularization; Stents

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REIMBURSEMENT; RETROPERITONEAL HEMORRHAGE;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; COSTS AND COST ANALYSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 35948961109     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-1099.
2. Schampaert E, Cohen EA, Schluter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43:1110-1115.
3. Stone GW, Ellis SG, Cox DA, et al for the TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004;109:1942-1947.
4. Dawkins KD, Grube E, Guagliumi G, et al on behalf of the TAXUS VI Investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial. Support for the use of drug-eluting stents in contemporary clinical practice. Circulation 2005;112:3306-3313.
5. Moses JW, Leon MB, Popma JJ, et al for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
6. Colombo A, Drzewiecki J, Banning A, et al for the TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788-794.
7. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing artery bypass graft with percutaneous transluminal coronary angioplasty: One- to eight-year out comes. J Am Coll Cardiol 2003;41:1293-1304.
8. Serruys PW, Ong ATL, Morice M-C, et al for the ARTS II Investigators. Arterial Revascularization Therapy Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary lesions. Euro Interv 2005;2:147-156.
9. Varani E, Balducelli M, Gatti C, et al. Cost of single-vessel and multivessel coronary drug-eluting stenting: Comparison to the DRG funding level. Ital Heart J 2005;6:52-58.
10. ASSR 2001 Data. Il Sole 24 Ore Sanità 2004;9:14-21
11. "Nomenclatore tariffario delle prestazioni ambulatoriali" del D.M. 22 luglio 1996. Data provided by web research on www.e-drg.it
12. "Determinazione delle tariffe per prestazioni di assistenza ospedaliera in strutture pubbliche e private accreditate della RER applicabili a decorrere dall'1-1-2005" Del. No 2126 del 19-12-2005. Data provided by web research on www.e-drg.it
13. Rodriguez A, Bernardi V, Navia J, et al, for the ERACI II Investigators. Argentine randomized study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. J Am Coll Cardiol 2001;37:51-58.
14. The SOS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): A randomised controlled trial. Lancet 2002; 360:965-970.
15. Serruys PW, Unger FG. Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124.
16. Ferreira AC, Peter AA, Salerno TA, et al. Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center. Ann Thorac Surg 2003;75:485-489.
17. Griffiths H, Bakhai A, West D, et al. Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease. Eur J Cardiothorac Surg 2004;26:528-534.
18. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005;352:2174-2183.
19. Detre KM, Guo P, Holubkov R, et al. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1999;99:633-640.
20. Gersh BJ, Frye RL. Methods of coronary revascularization - Things may not be as they seem. N Engl J Med 2005;352:2235-2237.
21. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": The rapamycin-eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) Registry. Circulation 2004;109:190-195.
22. Shishehbor MH, Lauer MS, Singh IM, et al. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 2007;49:849-854.
23. Campolo L. La scelta del miglior trattamento della coronaropatia con PCI ed i rimborsi dei DRG. Il paradosso della cardiochirurgia. Cardiologia Invasiva 2005;3(Suppl):210-203.
24. Arduini R, Colombo A, Genuini GF, et al. L'analisi dei DRG italiani e la pratica clinica in Italia. In: L'impatto economico dell'innovazione tecnologica nelle malattie dell'apparato cardiovascolare. Centro Studi Economia e Sanità- Business International Quaderno 16/2004, pp. 25-28.